Latest news

2022-05-09	Inify Laboratories – extra bolagsstämma 2022-05-09
2022-04-11	Inify Laboratories – kallelse till extra bolagsstämma

Corporate news

2022-03-31	ContextVision – Invitation to Annual General Meeting 2022
2022-03-31	ContextVision presents Annual Report 2021
2022-02-11	ContextVision – Information regarding dividend and reverse share split in Inify Laboratories
2022-02-02	ContextVision announces resolution regarding record date for dividend
2021-11-15	ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service
2021-10-18	INIFY Prostate® shown to accurately outline suspicious prostate cancer in study with two prominent medical centers
2021-08-31	In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites
2021-07-06	ContextVision announces agreement with two renowned US cancer centers for clinical evaluation of INIFY® Prostate
2021-03-30	ContextVision & The Pathologist's INIFY® webinar – now with on-demand access
2021-02-11	ContextVision announces signed contract with Vall d’Hebron for clinical evaluation of INIFY® Prostate Screening